Grand Rounds: Updates on Juvenile Idiopathic Arthritis (JIA)

Objectives (Educational Content) :

1. To discuss the diagnosis of JIA. 2. To understand some of the immunology surrounding JIA. 3. To explore new treatments in JIA.

Target Audience:

General pediatricians, family physicians, nurse practitioners, physician assistants, social workers, psychologists, and nurses.

Identified Gap:

Juvenile idiopathic arthritis is the most common childhood rheumatic condition with variable presentation and co-morbidities and associations therefore early and effective treatment is critical to reduce inflammation and pain while restoring our patients function and decreasing the long-term sequelae.

Estimated Time to Complete the Educational Activity:

1 hour(s)

Expiration Date for CE/CME Credit:

02-18-2026

Method of Participation in the Learning Process:

The learner will view the presentation, successfully complete a post-test and complete an activity evaluation.

Evaluation Methods:

All learners must successfully complete a post-test, as well as an activity evaluation, to claim CE/CME credit.

Disclosure:

The following presenter has indicated that there are no financial relationship with ineligible companies: Christopher Costin, MD, RhMSUS The following planning committee member has indicated that a financial relationship with an ineligible company: All relationships have been mitigated. The remaining planning committee/CME committee members have indicated that they have no financial relationships with any ineligible companies.

Accreditation Statement:

Akron Children’s Hospital is accredited by the Ohio State Medical Association to provide continuing medical education for physicians.

Akron Children’s Hospital designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Bibliography:

1. Thierry S, Fautrel B, Lemelle I, Guillemin F. Prevalence and incidence of juvenile idiopathic arthritis: A systematic review. Joint Bone Spine. 2014;81(2):112-117.

2. Kim ST, Muñoz-Grajales C, Dunn SE, et al. Interferon and interferon-induced cytokines as markers of impending clinical progression in ANA+ individuals without a systemic autoimmune rheumatic disease diagnosis. Arthritis Res Ther. 2023;25(1):21. doi:10.1186/s13075-023-02997-w

3. Weiss ES, Girard-Guyonvarc’h C, Holzinger D, et al. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome. Blood. 2018;131(13):1442-1455. doi:10.1182/blood-2017-12-820852